Criocord

What Criocord does

Criocord is a privately held Brazilian biotechnology company headquartered in Fortaleza, Ceará, operating since 2005 as a private Umbilical Cord and Placental Blood Bank (Banco de Sangue de Cordão Umbilical e Placentário). It positions itself as the first private cord blood bank in Ceará and the second in Northeast Brazil. The company serves expectant families through a direct-to-consumer model, contracting services before birth and coordinating collection at partner maternity hospitals in the Northeast region of Brazil. Its primary customers are individual families seeking private stem cell storage rather than public donation, with a secondary channel of referrals from obstetricians and gynecologists during prenatal care.

The company's core technical offering encompasses end-to-end umbilical cord blood processing: painless collection at partner maternities, temperature-controlled transport, automated cell separation using Sepax® technology licensed from BioSafe (Switzerland), closed-system processing producing high-recovery Buffy Coat concentrate, controlled-rate cryopreservation with monitoring graphs, and long-term storage in liquid nitrogen tanks maintained below -140°C in gas phase and -196°C in liquid phase with electricity-independent backup systems. Operations are conducted in a proprietary laboratory under a multidisciplinary team including hematologists, oncologists, obstetricians, and a biochemical pharmacist, and the company is compliant with Brazilian regulatory standard RDC N° 56/2010.

The business model relies on subscription-recurring revenue from upfront collection/processing fees plus ongoing annual storage fees paid by families. Marketing is conducted through educational content (blog, Instagram, email newsletter), participation in maternal health community events, and health awareness campaigns such as Outubro Rosa and Junho Vermelho. There is no publicly disclosed pricing. The company has not raised institutional funding rounds, has no disclosed headcount, and has not expanded beyond its Northeast Brazil regional footprint.

Name

Criocord

Legal name

Criocord

Website

https://criocord.com.br

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1–10 employees

Short description

Criocord is a private Brazilian cord blood bank founded in 2005 in Fortaleza, Ceará, providing expectant families with umbilical cord blood collection, automated Sepax-based processing, and long-term cryopreservation storage services across Northeast Brazil.

Ownership category

akta.pro rank

Product category

Stem Cell Banking Services

NAICS

Blood and Organ Banks (621991)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

Keywords

• Cord blood banking
• Stem cell cryopreservation
• Hematopoietic stem cell storage
• Placental blood banking
• Umbilical cord collection

Headquarters

HQ city

Fortaleza

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Cord Blood Stem Cell Banking Service: Private cord blood and placental blood collection, processing, and long-term cryopreservation service for families. Families contract services before birth and pay for collection, processing, and ongoing storage fees.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Criocord is a private Umbilical Cord and Placental Blood Bank that provides end-to-end hematopoietic stem cell banking services for expectant families. The service includes professional collection of cord blood at partner maternity hospitals, temperature-controlled transport, closed-system processing using Sepax® technology, and long-term cryopreservation in liquid nitrogen tanks at temperatures below -140°C. Families contract the service before birth and pay for collection, processing, and recurring storage for potential future therapeutic use.

Product overview

Criocord operates as a private Umbilical Cord and Placental Blood Bank (Banco de Sangue de Cordão Umbilical e Placentário) based in Fortaleza, Brazil. Founded in 2005, it is the first private cord blood bank in Ceará and the second in Northeastern Brazil. The company's core service offering centers on the collection, transport, processing, and cryopreservation of hematopoietic stem cells from umbilical cord blood and placental tissue. Criocord provides a complete integrated service that includes contractual documentation, professional collection at partner maternity hospitals, closed-system processing using Sepax technology, and long-term cryogenic storage in liquid nitrogen tanks. The company also offers educational content through its blog and scientific articles platform. All processes are conducted in-house with the company's own biotechnology laboratory structure, supported by a multidisciplinary team of hematologists, oncologists, obstetricians, and biochemists.

Differentiator

Problem solved

Functional benefit

Products and services

• Private Umbilical Cord and Placental Blood Banking End-to-end private stem cell banking service for expectant families, covering collection, transport, processing, and long-term cryopreservation of hematopoietic stem cells from umbilical cord blood and placental tissue for potential therapeutic use against blood diseases, immune disorders, and regenerative medicine applications.
• Umbilical Cord Blood Collection Service Painless, professional collection of umbilical cord blood at the time of birth, performed by qualified professionals at the partner maternity hospital, followed by temperature-controlled transport to the Criocord laboratory in Fortaleza.
• Stem Cell Processing and Cryopreservation Service Closed-system processing of collected cord blood using Sepax® automated cell-separation technology from BioSafe to produce high-quality Buffy Coat concentrate, followed by controlled-rate cryopreservation and long-term storage in liquid nitrogen tanks maintained at temperatures below -140°C (gas phase) and -196°C (liquid phase).

Quantifiable outcome

• Cryopreservation maintains cell viability and recovery for up to 11+ years of storage
• +2 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• ASBMT (American Society for Blood and Marrow Transplantation)coreStrategic or Co-development Partner · 1 January 2014Collaborative partnership for scientific research published in BBMT (Biology of Blood and Marrow Transplantation) journal. Study analyzed 288 cord blood samples demonstrating that cryopreservation time does not affect stem cell performance after thawing for medical use.
• BioSafe (Sepax Technology)coreTechnology or IntegrationTechnology provider for Sepax® automated cell separation system used in Criocord's laboratory for processing umbilical cord blood stem cells with high recovery rates.

Scale indicators4 records

Recent moves5 records

Expansion highlights3 records

Others

• CooperSurgical: US women's health and fertility company that owns CBR. Not a direct competitor to Criocord, but adjacent as a strategic acquirer of cord blood banking assets and a benchmark for the strategic value of established private cord blood inventories.

Direct peers

• CordVida: One of the largest private cord blood banks in Brazil, offering collection, processing, and long-term storage of umbilical cord blood stem cells. Direct competitor to Criocord in the same private banking model serving expectant Brazilian families.
• CryoHoldco: Latin American stem cell banking platform operating private cord blood banks across the region. Highly comparable to Criocord as a regional private banking peer with overlapping addressable market in Latin America.
• StemCyte: Hybrid public-private cord blood bank offering family banking services alongside public inventory. Comparable in technology stack and service offering, with international operations overlapping Criocord's therapeutic focus.

Broad incumbents

• ViaCord: Established US private cord blood and cord tissue bank offering family banking services. Operates with similar subscription/recurring revenue model and comparable clinical positioning to Criocord.
• Cryo-Cell International: US-listed pioneer in private cord blood banking with a global footprint. Comparable to Criocord in service offering (collection, processing, long-term cryopreservation) but materially larger scale, broader geographic reach, and public-market financial profile.
• Vita34: German-based private cord blood bank with more than 25 years of operating history. Comparable subscription-based storage model and clinical positioning, with European geographic focus.
• CBR (Cord Blood Registry): One of the largest US private cord blood banks, now part of CooperSurgical. Highly comparable in service model — private family banking with long-term cryopreservation — but operates at national US scale versus Criocord's regional footprint.
• FamiCord Group: European leader in family stem cell banking operating across multiple countries. Comparable to Criocord in core service (private cord blood and tissue banking) but with multi-country infrastructure and substantially larger processed inventory.

Regional players

• Banco de Cordon Umbilical (BCU): Spanish/European-origin cord blood bank with presence across multiple Spanish-speaking markets. Comparable service offering but operates in different geographies, making it a regional rather than direct competitor to Criocord in Brazil.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php
• Instagraminstagram.com/criocord

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Criocord